PreY inhibitors represent a class of chemical compounds that interfere with the enzymatic activity of the preY protein, which plays a critical role in various biological processes, particularly those related to cellular metabolism and regulatory mechanisms. The preY protein, typically part of a larger enzyme complex, is involved in the intricate pathways of cellular signaling and metabolic regulation. By inhibiting the function of preY, these compounds can significantly impact the biochemical pathways in which this protein is involved, leading to a modulation of the cellular environment. PreY inhibitors are often characterized by their specific binding affinities and modes of action, which can range from competitive inhibition, where they directly compete with the natural substrate of the enzyme, to allosteric inhibition, where they bind to a different site on the enzyme, inducing a conformational change that reduces its activity.
The design and synthesis of preY inhibitors are guided by the need to achieve high specificity and potency. Advanced techniques in computational chemistry and molecular biology are employed to elucidate the structure-activity relationships (SAR) that govern the interactions between these inhibitors and the preY protein. Structural biology methods, such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, provide detailed insights into the binding sites and the conformational dynamics of the enzyme. Additionally, kinetic studies are crucial for understanding the inhibitory mechanisms and the potential off-target effects. The development of preY inhibitors also involves rigorous chemical optimization to enhance their stability, solubility, and bioavailability within the experimental settings. Through these comprehensive approaches, researchers can better understand the fundamental aspects of enzyme inhibition and the broader implications for cellular and molecular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD-98059 is a selective inhibitor of mitogen-activated protein kinase kinase (MEK), which prevents the phosphorylation and activation of ERK1/2, downstream of preY. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a potent and selective inhibitor of MEK1/2, effectively blocking the activation of ERK1/2 signaling pathway mediated by preY, thus inhibiting cellular proliferation and survival. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of phosphatidylinositol 3-kinase (PI3K), which is downstream of preY signaling pathway. It inhibits cell proliferation and induces apoptosis. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another inhibitor of PI3K, which blocks the activation of AKT downstream of preY, leading to inhibition of cell growth, proliferation, and survival. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the activity of mammalian target of rapamycin (mTOR), a downstream effector of preY, thereby suppressing cell growth and protein synthesis. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAPK, which is downstream of preY signaling pathway. It inhibits the pro-inflammatory cytokine production and cell apoptosis. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits c-Jun N-terminal kinase (JNK), which is involved in cell growth, differentiation, and apoptosis downstream of preY. It blocks phosphorylation of c-Jun and inhibits AP-1 transcriptional activity. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
AG-490 is a JAK2 inhibitor, blocking the activation of JAK2/STAT3 signaling pathway downstream of preY. It inhibits cell proliferation, induces apoptosis, and suppresses tumor growth. | ||||||
Dibenzazepine (Deshydroxy LY 411575) | 209984-56-5 | sc-207554 sc-207554A | 2 mg 5 mg | $235.00 $260.00 | 4 | |
LY-411575 is a gamma-secretase inhibitor that blocks the cleavage of Notch receptor downstream of preY, inhibiting Notch signaling pathway involved in cell fate determination and differentiation. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib is an EGFR tyrosine kinase inhibitor, which targets the epidermal growth factor receptor (EGFR) downstream of preY signaling, inhibiting cell proliferation and inducing apoptosis. | ||||||